Pitt Shield

Bilateral Focused Ultrasound Thalamotomy for Essential Tremor: Clinical Outcomes Compared to Bilateral Deep Brain Stimulation and Probabilistic Lesion Mapping.

Authors: Sarica C, Yamamoto K, Iorio-Morin C, Germann J, Yang AZ, Santyr B, Colditz M, Vetkas A, Fomenko A, Davidson B, Schmidt F, Grippe T, Samuel N, Zemmar A, Flouty O, Cheyuo C, Darmani G, Chen R, Boutet A, Neudorfer C, Hodaie M, Kalia SK, Munhoz RP, Fasano A, Lozano AM

The efficacy and adverse events (AEs) of bilateral magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomies for essential tremor (ET) have not been compared to those of deep brain stimulation (DBS). Furthermore, it is uncertain whether second-side thalamotomies can be positioned differently from the first without compromising effectiveness. We aimed to indirectly compare bilateral MRgFUS and DBS, while identifying optimal lesion/stimulation locations. We retrospectively examined 41 ET patients who received either bilateral thalamic DBS (n = 22) or MRgFUS (n = 19) surgery. The primary outcome was the comparison of modalities for change in Clinical Rating Scale for Tremor (CRST) from baseline to post second surgery. We characterized AEs, generated probabilistic maps, and tracked streamlines intersecting lesions. First-side lesions were always intentionally placed ventrally (z = 0/+2 mm above the intercommissural plane [ICP]), and second-side lesions were placed dorsally (z = +3 mm above ICP). Tremor scores improved significantly after second surgeries (MRgFUS: 56.3 ± 7.1 to 24.2 ± 10.4, P < 0.001; DBS: 58.8 ± 11.6 to 25.0 ± 13, P < 0.05, mean follow-up: 23/26 months), with no differences between modalities. Following first surgeries, scores were MRgFUS: 37.9 ± 7.9 and DBS: 35.2 ± 13.6, with significant improvement from baseline (P < 0.001, mean follow-up: 40/73 months). All AEs were grade 1-2, with AE-free rates of 41% for DBS and 32% for MRgFUS. First-side lesions exhibited maximal efficacy in the ventral Vim, extending to posterior subthalamic area (PSA), whereas second-side lesions demonstrated maximal efficacy in the dorsomedial Vim-Vop border. DBS maps corroborated this finding and confined to Vim-Vop border. Lesions intersecting with networks interconnected with the supplementary motor area, in addition to M1, were associated with improved outcomes. The efficacies of bilateral MRgFUS and DBS appear comparable. MRgFUS probabilistic maps vary with different targeting methods, revealing two distinct sweet spots: dorsal Vim-Vop border and ventral Vim/PSA. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Introduction

Purpose Thermal ablation
Study Objective To indirectly compare bilateral MRgFUS and DBS for essential tremor and identify optimal lesion/stimulation locations.
Animal model / Human subject Human (Homo sapiens); strain: N/A; age: not reported; sex: not reported (patients with essential tremor, n=41: DBS n=22, MRgFUS n=19)
Disease model Essential tremor
MRI or image guidance method Magnetic resonance–guided focused ultrasound (MRgFUS) with stereotactic targeting referenced to the intercommissural plane (ICP): first-side ventral (z = 0/+2 mm above ICP), second-side dorsal (z = +3 mm above ICP)
Targeted brain region(s) Thalamus
Target coordinates First-side: z = 0 to +2 mm above the intercommissural plane (ICP); Second-side: z = +3 mm above ICP. AP and ML coordinates not specified.

Outcomes and Safety

Summary of Outcomes Bilateral MRgFUS thalamotomy produced tremor reduction comparable to bilateral DBS, with improved outcomes when lesions intersected thalamocortical fibers to the supplementary motor area (SMA) and primary motor cortex (M1). Two MRgFUS targeting parameters were successful: a ventral target (z = 0 to +2 mm) extending into the posterior subthalamic area (PSA) and a dorsal target (z = +3 mm) centered at the dorsomedial Vim–Vop border.
Duration of biological effect 4 years
Safety-related matter Both MRgFUS and DBS produced only mild adverse events (grade 1–2) with no ≥grade 3 AEs; AE‑free rates were 41% for DBS and 32% for MRgFUS. MRgFUS had a higher burden of persistent mild AEs after the second surgery (12/19 patients, 64%), while 55% of DBS AEs were stimulation‑dependent and often resolved when stimulation was turned off.

Brain Region

Ultrasound Parameters

Focal Characteristics focal depth: None; focal length: None; aperture size: None
Treatment frequency Multiple sessions

We are open to feedback. If you see a mistake or have a suggestion, please contact us.

← Back to Search